Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $21.43 million as of August 14, 2025. Its market cap has decreased by -84.34% in one year.

• Market Cap: 21.43M
• Enterprise Value: 57.50M
• 1-Year Change: -84.34%
• Ranking: #4895
• Category: Nano-Cap
• Stock Price: $0.48

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $21.43M, a decrease of -87.65%. That is a compound annual growth rate of -8.21%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	22.30M	-75.76%
Dec 31, 2024	92.00M	-59.72%
Dec 29, 2023	228.40M	97.92%
Dec 30, 2022	115.40M	-59.89%
Dec 31, 2021	287.70M	72.07%
Dec 31, 2020	167.20M	44.01%
Dec 31, 2019	116.10M	-2.11%
Dec 31, 2018	118.60M	3.04%
Dec 29, 2017	115.10M	9.83%
Dec 30, 2016	104.80M	-11.04%
Dec 31, 2015	117.80M	-35.91%
Dec 31, 2014	183.80M	26.15%
Dec 31, 2013	145.70M	15.45%
Dec 31, 2012	126.20M	14.42%
Dec 30, 2011	110.30M	-4.42%
Dec 31, 2010	115.40M	9.70%
Dec 31, 2009	105.20M	29.08%
Dec 31, 2008	81.50M	-42.24%
Dec 31, 2007	141.10M	-9.96%
Dec 29, 2006	156.70M	15.56%
Dec 30, 2005	135.60M	-3.49%
Dec 31, 2004	140.50M	-47.56%
Dec 31, 2003	267.90M	170.88%
Dec 31, 2002	98.90M	-62.67%
Dec 31, 2001	264.90M	52.68%

View and export this data all the way back to 2001. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	570.26B
Johnson & Johnson	418.62B
AbbVie	350.91B
AstraZeneca	229.47B
UnitedHealth Group	228.94B
Novartis AG	228.69B
Abbott Laboratories	228.63B
Novo Nordisk	222.88B